ID

12470

Description

The purpose of this trial is to evaluate the safety and indicators of efficacy of up to 4 doses of orally administered dabigatran etexilate, administered twice daily, compared to placebo when given in addition to dual antiplatelet treatment in patients with an index event (MI) at high risk for new ischaemic cardiovascular events. https://www.clinicaltrials.gov/ct2/show/NCT00621855

Lien

https://www.clinicaltrials.gov/ct2/show/NCT00621855

Mots-clés

Versions (2)
  1. 28/07/2015 28/07/2015 -
  2. 21/11/2015 21/11/2015 -
Téléchargé le

21 novembre 2015

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility RE-DEEM Acute Coronary Syndrome NCT00621855

Anglais

Eligibility criteria

1 Formulaires  
  1. StudyEvent: ODM
    1. Eligibility criteria
Inclusion criteria
Description

Inclusion criteria

Patients with acute coronary syndromes
Description

Patients with acute coronary syndromes

Type de données

boolean

Alias
UMLS CUI [1]
C0948089
with at least one additional risk factor for cardiovascular complications
Description

with at least one additional risk factor for cardiovascular complications

Type de données

boolean

Alias
UMLS CUI-1
C0741920
Exclusion criteria
Description

Exclusion criteria

Long term treatment with any other oral anticoagulant
Description

Long term treatment with any other oral anticoagulant

Type de données

boolean

Alias
UMLS CUI-1
C0354604
Severe/disabling stroke within last 6 months
Description

Severe/disabling stroke within last 6 months

Type de données

boolean

Alias
UMLS CUI-1
C0038454
Conditions associated with increased bleeding risk
Description

Conditions associated with increased bleeding risk

Type de données

boolean

Alias
UMLS CUI-1
C3251812
Anaemia
Description

Anaemia

Type de données

boolean

Alias
UMLS CUI-1
C0002871
Thrombocytopenia
Description

Thrombocytopenia

Type de données

boolean

Alias
UMLS CUI-1
C0040034
Severe renal impairment
Description

Severe renal impairment

Type de données

boolean

Alias
UMLS CUI-1
C0035078
Liver disease
Description

Liver disease

Type de données

boolean

Alias
UMLS CUI-1
C0085605
Positive pregnancy test
Description

Positive pregnancy test

Type de données

boolean

Alias
UMLS CUI-1
C0549206
Retour au début de la page

Similar models

Eligibility criteria

1 Formulaires
  1. StudyEvent: ODM
    1. Eligibility criteria
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
Inclusion criteria
Acute coronary syndrome
Item
Patients with acute coronary syndromes
boolean
C0948089 (UMLS CUI [1])
Cardiac risk factor
Item
with at least one additional risk factor for cardiovascular complications
boolean
C0741920 (UMLS CUI-1)
Item Group
Exclusion criteria
Oral Anticoagulants
Item
Long term treatment with any other oral anticoagulant
boolean
C0354604 (UMLS CUI-1)
Stroke
Item
Severe/disabling stroke within last 6 months
boolean
C0038454 (UMLS CUI-1)
Bleeding risk
Item
Conditions associated with increased bleeding risk
boolean
C3251812 (UMLS CUI-1)
Anaemia
Item
Anaemia
boolean
C0002871 (UMLS CUI-1)
Thrombocytopenia
Item
Thrombocytopenia
boolean
C0040034 (UMLS CUI-1)
Kidney failure
Item
Severe renal impairment
boolean
C0035078 (UMLS CUI-1)
Liver failure
Item
Liver disease
boolean
C0085605 (UMLS CUI-1)
Pregnancy
Item
Positive pregnancy test
boolean
C0549206 (UMLS CUI-1)
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial